Jpmorgan Chase & CO Vor Biopharma Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,667 shares of VOR stock, worth $14,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,667
Previous 12,038
11.39%
Holding current value
$14,613
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VOR
# of Institutions
57Shares Held
39MCall Options Held
9.3KPut Options Held
100-
Ra Capital Management, L.P. Boston, MA39.6MShares$54.3 Million0.71% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$8.72 Million3.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.66 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$1.47 Million0.41% of portfolio
-
Lynx1 Capital Management LP San Juan, PR637KShares$872,9880.27% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $52.1M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...